¡Ya estamos en ! Descubre más
6.02 USD
-0.09
1.47%
Al cierre Actualizado 16 oct, 4:00 p.m. EDT
1 día
-1.47%
5 días
-3.68%
1 mes
10.46%
3 meses
8.47%
6 meses
-19.52%
En lo que va del año
6.55%
1 año
-11.73%
5 años
-13.01%
10 años
45.06%
 

Acerca de: Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company also designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.

Empleados: 678

Noticias

Positivo
Neutral
Negativo
Sentimiento 3 meses
Positivo 57.1%
Neutral 42.9%
Negativo 0%
Positivo
Zacks Investment Research
hace 21 días
Ultralife Upgraded to Neutral on Backlog & Product Commercialization
ULBI's upgrade to Neutral reflects record backlog, product commercialization, manufacturing improvements and broader opportunities from vertical integration.
Ultralife Upgraded to Neutral on Backlog & Product Commercialization
Positivo
Seeking Alpha
hace 25 días
Ultralife: Well Positioned For Liquidity Despite Low Cash And Declining Cash Flow
Ultralife Corporation maintains a Buy rating, supported by strong working capital, declining debt, and improving profitability despite recent cash flow concerns. ULBI's Q2-2026 results show significant year-over-year gains in operating income and adjusted EBITDA, aided by a $1.1 million tariff refund. Liquidity risk is mitigated by a current ratio of 2.9, a quick ratio of 1.11, and management's confidence in converting inventory and receivables into cash.
Ultralife: Well Positioned For Liquidity Despite Low Cash And Declining Cash Flow
Positivo
Zacks Investment Research
hace 2 meses
Ultralife Stock Gains Post Q2 Earnings Despite Y/Y Revenue Dip
ULBI's earnings improve in second-quarter 2026 despite softer revenues, as stronger margins, record backlog and operational gains supported its profitable-growth outlook.
Ultralife Stock Gains Post Q2 Earnings Despite Y/Y Revenue Dip
Positivo
MarketBeat
hace 2 meses
Ultralife Q2 Earnings Call Highlights
Ultralife NASDAQ: ULBI reported second-quarter 2026 revenue of $47.9 million, operating income of $3.4 million and diluted earnings per share of $0.15, as the company cited stronger gross margins, a record backlog and continued investment in product development across its battery and communications businesses.
Ultralife Q2 Earnings Call Highlights
Neutral
Seeking Alpha
hace 2 meses
Ultralife Corporation (ULBI) Q2 2026 Earnings Call Transcript
Ultralife Corporation (ULBI) Q2 2026 Earnings Call Transcript
Ultralife Corporation (ULBI) Q2 2026 Earnings Call Transcript
Neutral
GlobeNewsWire
hace 2 meses
Ultralife Corporation Reports Second Quarter Results
NEWARK, N.Y., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2026 with the following results: Sales of $47.9 million compared to $48.6 million for the 2025 second quarter Gross profit of $13.9 million, or 28.9% of revenue, compared to $11.6 million, or 23.9% of revenue, for the 2025 second quarter; excluding a $1.1 million net IEEPA refund received in the 2026 second quarter, gross margin was 26.6% Operating income of $3.4 million, including one-time costs of $0.9 million, compared to $2.3 million including one-time costs of $0.3 million for the 2025 second quarter GAAP EPS of $0.15 compared to $0.05 for the 2025 second quarter Adjusted EBITDA of $6.1 million compared to $4.1 million for the 2025 second quarter Backlog of $117.5 million compared to $115.1 million exiting the first quarter of 2026 “For the second quarter we delivered a 760-basis point improvement in gross profit margin compared to the first quarter, including the contribution of the net IEEPA refund.
Ultralife Corporation Reports Second Quarter Results
Neutral
GlobeNewsWire
hace 2 meses
Ultralife Corporation to Report Second Quarter Results on August 7, 2026
NEWARK, N.Y., July 30, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2026, before the market opens on Friday, August 7, 2026.
Ultralife Corporation to Report Second Quarter Results on August 7, 2026
Negativo
Zacks Investment Research
hace 3 meses
Zacks Initiates Coverage of Ultralife With Underperform Recommendation
Discover why Zacks rates Ultralife as "Underperform", being the first on Wall Street to initiate coverage on the stock. Explore ULBI's struggles with execution risks, margin pressure and commercialization delays that could delay its earnings recovery.
Zacks Initiates Coverage of Ultralife With Underperform Recommendation
Negativo
MarketBeat
hace 5 meses
Ultralife Q1 Earnings Call Highlights
Ultralife NASDAQ: ULBI reported a first-quarter loss for fiscal 2026 as lower sales, production disruptions and higher one-time costs weighed on results, even as management pointed to a record backlog and new product activity as signs of future growth.
Ultralife Q1 Earnings Call Highlights
Neutral
Seeking Alpha
hace 5 meses
Ultralife Corporation (ULBI) Q1 2026 Earnings Call Transcript
Ultralife Corporation (ULBI) Q1 2026 Earnings Call Transcript
Ultralife Corporation (ULBI) Q1 2026 Earnings Call Transcript
Gráficos de precios implementados con Lightweight Charts™